Vassilios Raptopoulos
Diagnostic Radiology · Boston, MANPI 1952356719
Payments from drug & device makers
Across 103 payments — averaging $1039.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$52K
- Astrazeneca UK Limited$44K
- GSK$11K
Across 75 payments — averaging $3718.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tesaro, Inc.$154K
- GSK$54K
- Hoffmann-la Roche Limited$34K
- E.r. Squibb & Sons, L.L.C.$24K
- Regeneron$5K
- AbbVie$4K
- plus $3K from 2 others
What the payments were for
- Consulting fees$95,740100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 67 | $51,740 |
| Astrazeneca UK Limited | 22 | $44,000 |
| GSK | 14 | $11,300 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$107,040 in reported general payments places this provider in the 90th percentile of 1,206 diagnostic radiology providers in Massachusetts.
Other diagnostic radiology in Boston
- Stephan AndersonBoston$4.8M
- Gregg MillerBoston$4.2M
- Anthony SamirBoston$2.5M
- Mukesh HarisinghaniBoston$2.5M
- Albert YooBoston$2.1M
- Andrew KompelBoston$2M
- Ashraf ThabetBoston$2M
- Subba DigumarthyBoston$1.7M
- Udo HoffmannBoston$1.7M
- Clare TempanyBoston$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.